InvestorsHub Logo
Followers 13
Posts 1091
Boards Moderated 0
Alias Born 07/19/2013

Re: NASDAQ2020 post# 379813

Wednesday, 04/26/2023 1:55:05 PM

Wednesday, April 26, 2023 1:55:05 PM

Post# of 409422
Yes, with its subsidiary Accord Healthcare. Intas through Accord Healthcare recently acquired the generics business of Actavis in UK and Ireland.
Accord Healthcare has been operating in the US since 2009. Headquartered near Research Triangle in Durham, North Carolina, Accord Healthcare is the US subsidiary of Intas Pharmaceuticals with US annual sales of $668M*. Accord Healthcare’s US leadership team oversees development, clinical research, manufacturing, regulatory, and commercial activities related to its products.
https://www.accordhealthcare.us/our-team/

Intas Pharmaceuticals Ltd. (“Intas”), through its wholly owned subsidiary Accord Healthcare
Ltd. (“Accord”), announced today that it has entered into definitive agreements to acquire
Actavis UK Ltd. & Actavis Ireland Ltd. (“Actavis UK & Ireland”) from Teva Pharmaceutical
Industries Ltd.
(“Teva”) for an enterprise value of approximately £600 million payable in
cash.
The transaction is part of the European Commission’s anti-trust divestiture
requirements arising from Teva’s acquisition of Actavis Generics.

I wonder if they're looking to acquire/expand a generic business in the US as well.
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News